166 related articles for article (PubMed ID: 6401781)
1. Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
Fischer DG; Golightly MG; Koren HS
J Immunol; 1983 Mar; 130(3):1220-5. PubMed ID: 6401781
[TBL] [Abstract][Full Text] [Related]
2. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
[TBL] [Abstract][Full Text] [Related]
3. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
5. The role of monocyte cytotoxic factor (CF) in cytostasis mediated by IFN-gamma-activated monocytes.
Kildahl-Andersen O; Nissen-Meyer J
Immunology; 1985 Oct; 56(2):367-72. PubMed ID: 3932193
[TBL] [Abstract][Full Text] [Related]
6. Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.
Dean RT; Virelizier JL
Clin Exp Immunol; 1983 Mar; 51(3):501-10. PubMed ID: 6342884
[TBL] [Abstract][Full Text] [Related]
7. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
[TBL] [Abstract][Full Text] [Related]
8. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
Onozaki K; Matsushima K; Kleinerman ES; Saito T; Oppenheim JJ
J Immunol; 1985 Jul; 135(1):314-20. PubMed ID: 3873493
[TBL] [Abstract][Full Text] [Related]
10. Species-restricted effects of human and mouse lymphokines on macrophages.
Tagliabue A; Mantovani A; Boraschi D; Herberman RB
Eur J Immunol; 1980 Jul; 10(7):542-6. PubMed ID: 6157542
[TBL] [Abstract][Full Text] [Related]
11. Role of endotoxin in the expression of human monocyte cytotoxicity.
Biondi A; Peri G; Lorenzet R; Fumarola D; Mantovani A
J Reticuloendothel Soc; 1983 Apr; 33(4):315-27. PubMed ID: 6187919
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.
Feinman R; Henriksen-DeStefano D; Tsujimoto M; Vilcek J
J Immunol; 1987 Jan; 138(2):635-40. PubMed ID: 3098851
[TBL] [Abstract][Full Text] [Related]
13. Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin.
Horwitz DA; Bakke AC; Abo W; Nishiya K
J Immunol; 1984 May; 132(5):2370-4. PubMed ID: 6201542
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.
Sztein MB; Steeg PS; Johnson HM; Oppenheim JJ
J Clin Invest; 1984 Feb; 73(2):556-65. PubMed ID: 6230374
[TBL] [Abstract][Full Text] [Related]
15. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
16. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M; Banerjee D; Sklar S
Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
[TBL] [Abstract][Full Text] [Related]
17. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites.
Mantovani A; Bar Shavit Z; Peri G; Polentarutti N; Bordignon C; Sessa C; Mangioni C
Clin Exp Immunol; 1980 Mar; 39(3):776-84. PubMed ID: 6155233
[TBL] [Abstract][Full Text] [Related]
18. [Production and function of the monocyte cytotoxic factor (MCF)].
Uchida A
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2098-104. PubMed ID: 2440386
[TBL] [Abstract][Full Text] [Related]
19. Interactions between fresh human blood monocytes and tumor targets at the single cell level: binding and morphological characteristics.
Muse KE; Koren HS
J Reticuloendothel Soc; 1982 Nov; 32(5):323-37. PubMed ID: 6962303
[TBL] [Abstract][Full Text] [Related]
20. Gamma-interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes.
Schaffner A; Rellstab P
J Clin Invest; 1988 Sep; 82(3):913-9. PubMed ID: 2843576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
